|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03692 HANSOH PHARMA
Nominal 
13.540 -0.300 (-2.168%) Ranking Overview
Ranking based on 8 research report(s)
Average Ranking 2.38
|
Strong Buy (1)
0
|
Buy (2)
6
|
Hold (3)
1
|
Sell (4)
1
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2021 | EPS | 46.00 RMB (cts) | |
| Net Profit | 2,712.90 RMB (MIL) | DPS | 7.32 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2022 | 2,815.50 | 47.00 | 7.00 | -- | 2,909.00 | 2,642.00 |
| 2023 | 3,131.00 | 52.90 | 7.74 | -- | 3,353.00 | 2,910.00 |
| 2024 | 3,540.00 | 59.80 | 10.00 | -- | 4,053.00 | 3,180.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2022 | 2,899.80 | 49.00 | 7.74 | UOB | Buy | 20.00 | 22/02/2023 | |
| 2022 | 2,716.35 | 46.00 | -- | JEFFERIES HK | Buy | 20.00 | 26/01/2023 | |
| 2022 | 2,642.00 | 44.09 | -- | NOMURA | Buy | 19.49 | 09/03/2023 | |
| 2022 | 2,694.00 | 45.00 | -- | HSBC | Hold | 18.20 | 13/01/2023 | |
| 2022 | 2,896.00 | 48.00 | 7.00 | UBS | Buy | 18.10 | 03/01/2023 | |
| 2022 | 2,909.00 | 49.10 | 7.40 | CLSA | Buy | 17.30 | 18/10/2022 | |
| 2022 | 2,739.00 | 46.00 | 7.00 | CICC | OutPerform | 16.00 | 24/10/2022 | |
| 2022 | 2,892.00 | 48.80 | -- | BANK OF AMERICA | UnderPerform | 14.20 | 13/12/2022 | |
| 2023 | 3,267.50 | 55.20 | 7.74 | UOB | -- | -- | 22/02/2023 | |
| 2023 | 2,995.09 | 51.00 | -- | JEFFERIES HK | -- | -- | 26/01/2023 | |
| 2023 | 3,035.00 | 50.65 | -- | NOMURA | -- | -- | 09/03/2023 | |
| 2023 | 2,910.00 | 49.00 | -- | HSBC | -- | -- | 13/01/2023 | |
| 2023 | 3,353.00 | 56.00 | 8.00 | UBS | -- | -- | 03/01/2023 | |
| 2023 | 3,331.00 | 56.20 | 8.40 | CLSA | -- | -- | 18/10/2022 | |
| 2023 | 3,073.00 | 52.00 | 8.00 | CICC | -- | -- | 24/10/2022 | |
| 2023 | 3,189.00 | 53.80 | -- | BANK OF AMERICA | -- | -- | 13/12/2022 | |
| 2024 | 3,433.09 | 58.00 | -- | JEFFERIES HK | -- | -- | 26/01/2023 | |
| 2024 | 3,821.80 | 64.60 | 10.32 | UOB | -- | -- | 22/02/2023 | |
| 2024 | 3,516.00 | 58.67 | -- | NOMURA | -- | -- | 09/03/2023 | |
| 2024 | 3,180.00 | 54.00 | -- | HSBC | -- | -- | 13/01/2023 | |
| 2024 | 3,799.00 | 63.00 | 10.00 | UBS | -- | -- | 03/01/2023 | |
| 2024 | 4,053.00 | 68.40 | 10.30 | CLSA | -- | -- | 18/10/2022 | |
| 2024 | 3,540.00 | 59.80 | -- | BANK OF AMERICA | -- | -- | 13/12/2022 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 27/03/2023 18:00 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,297,976 |
| %Change | 0.572% |
| EPS / (LPS) | RMB 0.220 |
| NBV Per Share (¥) | RMB 3.567 |